Regenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI. The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”
-
Research
- Experts
In The News
View All
WFYI features Regenstrief Institute Study
WFYI featured a study by Regenstrief Institute and the IU...
Influence
View All
Supply, demand, and a growing US kidney transplant waiting list
Published in JAMA Network Open. Here is a link to...
- Opportunities
- Experts
Influence
January 9, 2020
Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners
Related News
Research letter calls for careful consideration of design and consequences of health disparity incentives in future value-based payment models
INDIANAPOLIS – A research letter published in the New England Journal of Medicine calls for careful consideration of the
Regenstrief Institute conference highlights innovations in public health data modernization
Regenstrief Institute hosted a one-day conference focused on advancing public health data modernization, drawing professionals from across the public
Supply, demand, and a growing US kidney transplant waiting list
Published in JAMA Network Open. Here is a link to the article. Regenstrief Institute author: Rachel Patzer, PhD, MPH
